carvedilol and aldosterone

carvedilol has been researched along with aldosterone in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (37.50)	18.2507
2000's	4 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Dupont, AG	1
Goldsmith, R; Gu, A; Krum, H; Medina, N; Miller, M; Packer, M; Sackner-Bernstein, J; Wilshire-Clement, M; Yushak, M	1
Barone, FC; Campbell, WG; Feuerstein, GZ; Laragh, JH; Nelson, AH; Ohlstein, EH; Sealey, JE; Willette, RN	1
Burchardt, H; Davidsen, U; Heitmann, M; Petersen, EB; Rasmussen, K; Stokholm, KH	1
Chan, S; Fung, JW; Nicholls, MG; Richards, AM; Sanderson, JE; Yandle, TG; Yip, G; Yu, CM	1
Gao, LJ; Lin, XY; Xiao, LZ; Zhang, HF	1
Aggarwal, A; Campbell, DJ; Wong, J	1
Ashraf, H; Bahreini, M; Ghoghaei, M; Najmeddin, F; Rasooli, F; Salehi, M; Soleimani, A; Solhjoo, M	1

Trials

6 trial(s) available for carvedilol and aldosterone

Article	Year
Effects of carvedilol on renal function. European journal of clinical pharmacology, 1990, Volume: 38 Suppl 2 Topics: Adrenergic beta-Antagonists; Adult; Aldosterone; Blood Pressure; Carbazoles; Carvedilol; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Kidney; Male; Middle Aged; Propanolamines; Randomized Controlled Trials as Topic; Renal Circulation; Renin	1990
Changes in plasma endothelin-1 levels reflect clinical response to beta-blockade in chronic heart failure. American heart journal, 1996, Volume: 131, Issue:2 Topics: Adrenergic beta-Antagonists; Aldosterone; Carbazoles; Carvedilol; Double-Blind Method; Endothelins; Female; Free Radical Scavengers; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Time Factors	1996
Renal and cardiac function during alpha1-beta-blockade in congestive heart failure. Scandinavian journal of clinical and laboratory investigation, 2002, Volume: 62, Issue:2 Topics: Adrenergic beta-Antagonists; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Carbazoles; Cardiac Output; Carvedilol; Diuretics; Drug Therapy, Combination; Glomerular Filtration Rate; Heart; Heart Failure; Heart Rate; Humans; Kidney; Middle Aged; Propanolamines; Renal Circulation	2002
Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure. The American journal of cardiology, 2003, Aug-15, Volume: 92, Issue:4 Topics: Adrenergic beta-Antagonists; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Carbazoles; Carvedilol; Drug Therapy, Combination; Heart Failure; Humans; Metoprolol; Natriuretic Peptide, Brain; Propanolamines; Renin; Ventricular Function, Left	2003
[Effects of carvedilol on neurohormone and magnesium metabolism in patients with chronic heart failure]. Zhonghua xin xue guan bing za zhi, 2005, Volume: 33, Issue:11 Topics: Adrenergic beta-Antagonists; Adult; Aged; Aldosterone; Angiotensin II; Carbazoles; Carvedilol; Female; Heart Failure; Humans; Magnesium; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Propanolamines	2005
Effects of Renin-Angiotensin-Aldosterone Inhibitors on Early Outcomes of Hypertensive COVID-19 Patients: A Randomized Triple-Blind Clinical Trial. American journal of hypertension, 2021, 11-20, Volume: 34, Issue:11 Topics: Aldosterone; Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Antihypertensive Agents; Carvedilol; COVID-19; Humans; Hypertension; Iran; Mineralocorticoid Receptor Antagonists; Renin	2021

Other Studies

2 other study(ies) available for carvedilol and aldosterone

Article	Year
Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats. The Journal of pharmacology and experimental therapeutics, 1996, Volume: 279, Issue:2 Topics: Adrenergic beta-Antagonists; Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Carbazoles; Carvedilol; Heart Rate; Hypertension; Kidney; Male; Propanolamines; Propranolol; Rabbits; Rats; Rats, Inbred SHR; Renin	1996
Carvedilol reduces aldosterone release in systolic heart failure. Heart, lung & circulation, 2006, Volume: 15, Issue:5 Topics: Adrenergic beta-Antagonists; Aldosterone; Biomarkers; Carbazoles; Carvedilol; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Radioimmunoassay; Severity of Illness Index; Stroke Volume; Systole; Treatment Outcome	2006

Article

Year

Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats.

The Journal of pharmacology and experimental therapeutics, 1996, Volume: 279, Issue:2

Topics: Adrenergic beta-Antagonists; Aldosterone; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Carbazoles; Carvedilol; Heart Rate; Hypertension; Kidney; Male; Propanolamines; Propranolol; Rabbits; Rats; Rats, Inbred SHR; Renin

1996

Carvedilol reduces aldosterone release in systolic heart failure.

Heart, lung & circulation, 2006, Volume: 15, Issue:5

Topics: Adrenergic beta-Antagonists; Aldosterone; Biomarkers; Carbazoles; Carvedilol; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Radioimmunoassay; Severity of Illness Index; Stroke Volume; Systole; Treatment Outcome

2006